ahlam1399
09-25-2015, 01:15 PM
UPDATE 1-**vartis? major heart drug recommended for EU approval
ZURICH, Sept 25 (Reuters) - **vartis AG's new heart failure drug, Entresto, has been recommended for approval in Europe by the European Medicines Agency's review body, the company said on Friday.
http://rc.feedsportal.com/r/238386371651/u/49/f/654213/c/35217/s/4a2726d2/sc/14/rc/1/rc.img (http://rc.feedsportal.com/r/238386371651/u/49/f/654213/c/35217/s/4a2726d2/sc/14/rc/1/rc.htm)
http://rc.feedsportal.com/r/238386371651/u/49/f/654213/c/35217/s/4a2726d2/sc/14/rc/2/rc.img (http://rc.feedsportal.com/r/238386371651/u/49/f/654213/c/35217/s/4a2726d2/sc/14/rc/2/rc.htm)
http://rc.feedsportal.com/r/238386371651/u/49/f/654213/c/35217/s/4a2726d2/sc/14/rc/3/rc.img (http://rc.feedsportal.com/r/238386371651/u/49/f/654213/c/35217/s/4a2726d2/sc/14/rc/3/rc.htm)
http://da.feedsportal.com/r/238386371651/u/49/f/654213/c/35217/s/4a2726d2/sc/14/a2.img (http://da.feedsportal.com/r/238386371651/u/49/f/654213/c/35217/s/4a2726d2/sc/14/a2.htm)
http://adchoice.feedsportal.com/r/238386371651/u/49/f/654213/c/35217/s/4a2726d2/sc/14/ach.img (http://adchoice.feedsportal.com/r/238386371651/u/49/f/654213/c/35217/s/4a2726d2/sc/14/ach.htm)http://pi.feedsportal.com/r/238386371651/u/49/f/654213/c/35217/s/4a2726d2/sc/14/a2t.imghttp://pi2.feedsportal.com/r/238386371651/u/49/f/654213/c/35217/s/4a2726d2/sc/14/a2t2.imghttp://i2.wp.com/reuters.us.feedsportal.com/c/35217/f/654213/s/4a2726d2/sc/14/mf.gif?resize=1%2C1http://feeds.feedburner.com/~ff/reuters/companyNews?d=yIl2AUoC8zA (http://feeds.reuters.com/~ff/reuters/companyNews?a=_NBGCZN-vzE:x9w1zxG4sdk:yIl2AUoC8zA) http://feeds.feedburner.com/~ff/reuters/companyNews?i=_NBGCZN-vzE:x9w1zxG4sdk:V_sGLiPBpWU (http://feeds.reuters.com/~ff/reuters/companyNews?a=_NBGCZN-vzE:x9w1zxG4sdk:V_sGLiPBpWU) http://feeds.feedburner.com/~ff/reuters/companyNews?i=_NBGCZN-vzE:x9w1zxG4sdk:F7zBnMyn0Lo (http://feeds.reuters.com/~ff/reuters/companyNews?a=_NBGCZN-vzE:x9w1zxG4sdk:F7zBnMyn0Lo)
http://feeds.feedburner.com/~r/reuters/companyNews/~4/_NBGCZN-vzE
ZURICH, Sept 25 (Reuters) - **vartis AG's new heart failure drug, Entresto, has been recommended for approval in Europe by the European Medicines Agency's review body, the company said on Friday.
http://rc.feedsportal.com/r/238386371651/u/49/f/654213/c/35217/s/4a2726d2/sc/14/rc/1/rc.img (http://rc.feedsportal.com/r/238386371651/u/49/f/654213/c/35217/s/4a2726d2/sc/14/rc/1/rc.htm)
http://rc.feedsportal.com/r/238386371651/u/49/f/654213/c/35217/s/4a2726d2/sc/14/rc/2/rc.img (http://rc.feedsportal.com/r/238386371651/u/49/f/654213/c/35217/s/4a2726d2/sc/14/rc/2/rc.htm)
http://rc.feedsportal.com/r/238386371651/u/49/f/654213/c/35217/s/4a2726d2/sc/14/rc/3/rc.img (http://rc.feedsportal.com/r/238386371651/u/49/f/654213/c/35217/s/4a2726d2/sc/14/rc/3/rc.htm)
http://da.feedsportal.com/r/238386371651/u/49/f/654213/c/35217/s/4a2726d2/sc/14/a2.img (http://da.feedsportal.com/r/238386371651/u/49/f/654213/c/35217/s/4a2726d2/sc/14/a2.htm)
http://adchoice.feedsportal.com/r/238386371651/u/49/f/654213/c/35217/s/4a2726d2/sc/14/ach.img (http://adchoice.feedsportal.com/r/238386371651/u/49/f/654213/c/35217/s/4a2726d2/sc/14/ach.htm)http://pi.feedsportal.com/r/238386371651/u/49/f/654213/c/35217/s/4a2726d2/sc/14/a2t.imghttp://pi2.feedsportal.com/r/238386371651/u/49/f/654213/c/35217/s/4a2726d2/sc/14/a2t2.imghttp://i2.wp.com/reuters.us.feedsportal.com/c/35217/f/654213/s/4a2726d2/sc/14/mf.gif?resize=1%2C1http://feeds.feedburner.com/~ff/reuters/companyNews?d=yIl2AUoC8zA (http://feeds.reuters.com/~ff/reuters/companyNews?a=_NBGCZN-vzE:x9w1zxG4sdk:yIl2AUoC8zA) http://feeds.feedburner.com/~ff/reuters/companyNews?i=_NBGCZN-vzE:x9w1zxG4sdk:V_sGLiPBpWU (http://feeds.reuters.com/~ff/reuters/companyNews?a=_NBGCZN-vzE:x9w1zxG4sdk:V_sGLiPBpWU) http://feeds.feedburner.com/~ff/reuters/companyNews?i=_NBGCZN-vzE:x9w1zxG4sdk:F7zBnMyn0Lo (http://feeds.reuters.com/~ff/reuters/companyNews?a=_NBGCZN-vzE:x9w1zxG4sdk:F7zBnMyn0Lo)
http://feeds.feedburner.com/~r/reuters/companyNews/~4/_NBGCZN-vzE